Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform. The company believes that SmartChip is ideal for researchers seeking to confirm discoveries made with the growing use of next-generation sequencing. In addition, the high throughput capabilities of the SmartChip system enable researchers to extend their research across large panels of genes, and hundreds of samples, at a very reasonable cost.
Combined with next-generation chemistry and optimized assays being developed by WaferGen under the guidance of David Gelfand, Ph.D., Chief Scientific Officer and one of the pioneers of PCR, the SmartChip system is designed to provide accurate, highly sensitive and high-throughput gene expression profiling capabilities to researchers, clinicians and pharmaceutical companies.
In addition, the company offers an innovative fee-based service for gene-expression profiling using the SmartChip system. For additional information, please see http://www.wafergen.com.
Forward-Looking Statements This press release contains certain "forward-looking statements". Such statements include statements relating to the expected benefits of the SmartChip Real-Time PCR system with respect to next generation sequencing and health care costs, statements relating to the expected benefits and advantages of the SmartChip service for gene-expression research, statements relating to the expected benefits and advantages of the SmartChip technology to other applications, statements relating to the potential new markets for the company and other statements relating to future events are not historical facts, including statements which may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words.
Forward-looking statements are not guarantees
Page: 1 2 3 4 5 Related medicine technology :1
|SOURCE WaferGen Biosystems, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. WaferGen Announces $7 Million Capital Raise -- $5 Million Equity Private Placement Agreement Signed, and $2 Million Credit Facility Closed2
. WaferGen Reports Second Quarter 2010 Financial Results3
. WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System4
. WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System5
. Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 20116
. Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition7
. Netsmart Technologies Software Supports Shawnee Mental Health Center Integrated Mental Health and Primary Care Initiative8
. Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning9
. Systech and Pester Pac Automation Exhibit Integrated Serialization Solution at Pack Expo 201010
. Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors11
. Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa®